| 标题 |
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of oncology : official journal of the European Society for Medical Oncology 作者:Tobinai K; Kobayashi Y; Narabayashi M; Ogura M; Kagami Y; et al 出版日期:1998/05/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)